Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The listed 21 genes showed highly significant (p < 0.007) difference between the two groups in our microarray study (n = 4 rat for each group)16.pFold changeName of gene productRefSeqUniGene code0.0000125.732islet amyloid polypeptideNM_012586Rn.113940.000150.466similar to RNA binding motif protein 3XM_001063211Rn.180570.000160.422aldo-keto reductase family 1, member B7NM_053781Rn.327020.000310.469S100 calcium-binding protein A4NM_012618Rn.5040.000340.442microtubule-associated protein tauNM_017212Rn.24550.000450.415similar to macrophage scavenger receptor 2XM_001067252Rn.768190.000500.438procollagen, type III, alpha 1NM_032085Rn.32470.000520.465similar to aldo-keto reductase family 1, member C19XM_001062695Rn.163710.000520.392similar to ectonucleotide pyrophosphatase/phosphodiesterase 6XM_001056025Rn.84840.000590.359KiSS-1 metastasis-suppressorNM_181692Rn.660080.000600.490hypothetical proteinXM_001066258Rn.1392260.000690.367calbindin 3, (vitamin D-dependent calcium binding protein)NM_012521Rn.99740.000840.373asialoglycoprotein receptor 1 (hepatic lectin)NM_012503Rn.443000.001440.401similar to procollagen, type I, alpha 1XM_001081230Rn.29530.002002.653ELL associated factor 2NM_172047Rn.206810.002073.720dopamine receptor 4NM_012944Rn.101590.002770.415similar to Paired mesoderm homeobox protein 2 (PRX-2) (Paired-related homeobox protein 2)XM_001079701Rn.93004 0.00281 2.186 insulin-like growth factor binding protein 3 NM_012588 Rn.26369 0.005372.473follistatinNM_012561Rn.1625570.005460.439ring finger protein 141NM_001001800Rn.1279900.006852.152selectin, endothelial cellNM_138879Rn.10359

Source: Genes with altered mRNA expression in the preoptic area of rat dams. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Rats were housed three per cage at a temperature of 22 ± 1 °C before experiments.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness

Study design awaiting verification · Scientific Reports · 2017

Original publication title

Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness

András H. Lékó; Melinda Cservenák; Éva Rebeka Szabó; János Hanics; Alán Alpár; Árpád Dobolyi

© The Author(s) 2017

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Adaptation to motherhood includes maternal behaviour and lactation during the postpartum period. The major organizing centres of maternal behaviour and lactation are located in the hypothalamic medial preoptic area (MPOA) and the arcuate nucleus, respectively. Insulin-like growth factor I (IGF-I) is an effector of the growth hormone axis; however, its function in the brain is largely unexplored. We identified increased maternal IGF binding protein-3 (IGFBP-3) expression in preoptic rat microarray data and confirmed it by RT-PCR. In situ hybridization histochemistry showed markedly elevated IGFBP-3 expression in the MPOA and the arcuate nucleus in rat dams.

Prolonged intracerebroventricular injection of IGF-I or antagonism of brain IGFBP-3 with an inhibitor (NBI-31772) using osmotic minipumps increased pup retrieval time, suggesting reduced maternal motivation. Suckling-induced prolactin release and pup weight gain were also suppressed by IGF-I, suggesting reduced lactation. In addition, IGF-I-induced tyrosine hydroxylase expression and its specific phosphorylation in tuberoinfundibular dopaminergic neurons suppress prolactin secretion. Thus, IGF-I may inhibit both behavioural and lactational alterations in mothers. Neurons in the MPOA and arcuate nuclei express IGFBP-3 during the postpartum period to neutralize IGF-I effects.

IGFBP-3 can prevent the blockade of maternal behaviour and lactation exerted by IGF-I, suggesting a novel modulatory mechanism underlying the behavioural and hormonal effects during central maternal adaptations.

Authors’ abstract

Adaptation to motherhood includes maternal behaviour and lactation during the postpartum period. The major organizing centres of maternal behaviour and lactation are located in the hypothalamic medial preoptic area (MPOA) and the arcuate nucleus, respectively. Insulin-like growth factor I (IGF-I) is an effector of the growth hormone axis; however, its function in the brain is largely unexplored. We identified increased maternal IGF binding protein-3 (IGFBP-3) expression in preoptic rat microarray data and confirmed it by RT-PCR. In situ hybridization histochemistry showed markedly elevated IGFBP-3 expression in the MPOA and the arcuate nucleus in rat dams.

Prolonged intracerebroventricular injection of IGF-I or antagonism of brain IGFBP-3 with an inhibitor (NBI-31772) using osmotic minipumps increased pup retrieval time, suggesting reduced maternal motivation. Suckling-induced prolactin release and pup weight gain were also suppressed by IGF-I, suggesting reduced lactation. In addition, IGF-I-induced tyrosine hydroxylase expression and its specific phosphorylation in tuberoinfundibular dopaminergic neurons suppress prolactin secretion. Thus, IGF-I may inhibit both behavioural and lactational alterations in mothers. Neurons in the MPOA and arcuate nuclei express IGFBP-3 during the postpartum period to neutralize IGF-I effects.

IGFBP-3 can prevent the blockade of maternal behaviour and lactation exerted by IGF-I, suggesting a novel modulatory mechanism underlying the behavioural and hormonal effects during central maternal adaptations.

Publication and source details

Original title: Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness

András H. Lékó; Melinda Cservenák; Éva Rebeka Szabó; János Hanics; Alán Alpár; Árpád Dobolyi

Scientific Reports · 2017

© The Author(s) 2017https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:38:14.032144+00:00

DOI: 10.1038/s41598-017-03645-5 · PMC5469809